Programme

19th September 2026 Saturday

Time Session
07:00
07:30
Congress Registration
07:30
08:15
Meet the Expert 1
How do I Manage Patients with Acute Liver Failure
Chieh-Hsin Huang Moderator
  • How do I Manage Patients with Acute Liver Failure
    Kathleen Liu Speaker How do I Manage Patients with Combined Kidney and Liver FailureKidney-Ventilator Interactions and Kidney Protective Ventilation /or Lung and Kidney CrosstalkHow do I care for the Patient with ARDS and AKIDe-escalating and Transitioning RRT: Best Practices
    Mitra Nadim Speaker Hepatorenal Syndrome: Recognition and Management or Disordered Physiology or Iatrogenic FailureManaging Patients With Combined Kidney and Liver FailureHow do I Manage Patients with Combined Kidney and Liver Failure
Meet the Expert 2
Practical Steps to Train (and Become) an AI-Era Physician
Chieh-Liang Wu Moderator
  • Practical Steps to Train (and Become) an AI-Era Physician
    Kianoush Kashani Speaker Practical Steps to Train (and Become) an AI-Era PhysicianAI in Critical Care Nephrology — State of the Art and the Path from Algorithm to BedsideLate breaking clinical trials or Critical Care Nephrology: Literature Review AI in the ICU or Chat GPT Applications in Critical Care Nephrology
    Rolando Claure-Del Granado Speaker Practical Steps to Train (and Become) an AI-Era PhysicianPrecision Solute Control and Dynamic Dosing with CRRTSocial Determinants of Health and Acute Kidney Injury
Meet the Expert 3
Severe Hypernatremia and Hyperkalemia in AKI Requiring KRT
Yung-Ho Hsu Moderator
  • Severe Hypernatremia and Hyperkalemia in AKI Requiring KRT
    Ashita Tolwani Speaker The ABC of the CRRT prescriptionPrescribing continuous renal replacement therapy requires an understanding of how modality, blood flow, treatment dose, replacement-fluid delivery, and circuit factors influence therapy delivery. This presentation will provide a practical framework for developing and evaluating a CRRT prescription, including the principles of diffusive and convective clearance, prescribed versus delivered dose, and the impact of replacement-fluid location and treatment interruptions. Clinical examples will highlight common prescribing challenges and demonstrate how CRRT settings can be adjusted to meet changing patient needs while maintaining effective and safe therapy.AnticoagulationEffective anticoagulation is essential to maintain circuit patency, minimize blood loss, and ensure delivery of the prescribed CRRT dose. This presentation will review the principles guiding anticoagulant selection during CRRT, including the relative roles of regional citrate anticoagulation, unfractionated heparin, and alternative agents. Particular emphasis will be placed on balancing circuit longevity with patient safety, recognizing patients at increased risk for bleeding or citrate intolerance, and monitoring for metabolic and anticoagulation-related complications. Dysnatremia and acid-base disordersContinuous renal replacement therapy can be adapted to safely manage severe sodium and acid–base disturbances. This presentation will review a practical approach to modifying the CRRT prescription based on the patient’s serum sodium, acid–base status, and desired rate of correction. Emphasis will be placed on anticipating how CRRT solutions and treatment settings influence biochemical changes and on avoiding overly rapid correction or treatment-related complications. Clinical examples will illustrate key principles for individualized therapy.Severe hypernatremia and hyperkalemia in AKI requiring KRTManaging Patients With Combined Kidney and Liver Failure
    Manish Kaushik Speaker
08:30
10:15
Plenary 1: Organ Dysfunction in the Critically Ill Patient: Emerging Concepts
Chih-Wei Yang Moderator
Pharmacist Symposium (in Mandarin)
Advancing Kidney Care through Pharmacist Expertise
Hui-Yu Chen Moderator
  • From AKI to Recovery: Medication Reconciliation and Polypharmacy Management
    Chia-Chi Chen Speaker From AKI to Recovery: Medication Reconciliation and Polypharmacy Management
    Shu-Wen Lin Moderator
  • Cardio-Renal Syndrome in the ICU: Pharmacological Challenges in Multi-Organ Support
    Ya-Tzu Chang Speaker Cardio-Renal Syndrome in the ICU: Pharmacological Challenges in Multi-Organ SupportThis lecture will provide an overview of pharmacological management in cardiorenal syndrome and discuss its clinical application and therapeutic dilemmas through case-based discussion. Cardiorenal syndrome refers to a pathophysiological condition in which dysfunction of the heart or kidney induces acute or chronic dysfunction in the other organ. Pharmacological strategies include decongestion therapy and medications with cardiorenal protective effects, such as RAAS inhibitors, ARNIs, MRAs, and SGLT2 inhibitors. In clinical practice, treatment decisions must consider the patient’s hemodynamic status, renal function, electrolyte abnormalities, and overall clinical stability. The goal is to balance therapeutic benefits and potential harms while optimizing cardiac and renal protection in critically ill patients.
    Chian-Ying Chou Moderator
  • Coffee Break
  • Nephrotoxic Drug Stewardship (NDS): Leveraging Real-World Data for AKI Prevention
    Yi-Ming Hua Speaker Nephrotoxic Drug Stewardship (NDS): Leveraging Real-World Data for AKI Prevention藥物及腎毒性物質暴露是住院病人急性腎損傷（AKI）重要且可介入的危險因子。腎毒性藥物管理（NDS）並非單純停用腎毒性藥物，而是透過腎功能動態監測、腎毒性負荷評估、劑量調整、治療藥物監測、交互作用辨識、替代藥物選擇及用藥整合，在治療效益與腎臟安全之間取得平衡。電子病歷中的腎功能、用藥暴露、藥物濃度、共病及臨床結局等真實世界資料，可用於建立高風險分層與臨床決策支援。然而，單獨的電子警示未必能改善結果，必須結合具體可執行的建議、藥師介入及跨專業追蹤。本演講將以腎功能相關劑量調整及多重腎毒性藥物暴露為例，說明如何建立「風險辨識、即時介入、成效追蹤、回饋改善」的 NDS 模式，以降低藥物相關 AKI，同時維持必要治療的有效性。
    Hui-Chen Su Moderator
  • Optimizing Pre-ESRD Care: Impact of Pharmacist-Led Clinics
    Yen-Hao Liao Speaker Optimizing Pre-ESRD Care: Impact of Pharmacist-Led ClinicsChronic kidney disease (CKD) is associated with complex medication regimens, polypharmacy, and an increased risk of drug-related problems, particularly in patients with pre-end-stage renal disease (Pre-ESRD). This session will highlight the role of pharmacist-led clinics in optimizing medication therapy management within a multidisciplinary care model. Drawing on real-world clinical experience and research findings, the presentation will discuss how pharmacist interventions can improve medication adherence, identify and resolve drug-related problems, reduce inappropriate medication use, and support better clinical outcomes. The session will also explore the evolving role of clinical pharmacists in delivering patient-centered care and enhancing the quality of Pre-ESRD management.
    Hui-Yu Chen Moderator
  • Using Meta-Analysis to Evaluate the Risk of AKI Associated with IVI Drugs
    Shih-Chieh Shao Speaker Using Systematic Review and Meta-Analysis to Evaluate the Risk of AKI Associated with IVI DrugsIntravitreal anti-vascular endothelial growth factor (anti-VEGF) drugs are widely used to treat retinal diseases, but concerns remain regarding their potential systemic effects, including acute kidney injury (AKI). This presentation will demonstrate how systematic review and meta-analysis can be applied to evaluate rare safety outcomes associated with intravitreal therapies.
    Kai-Cheng Chang Moderator
  • Panel Discussion & Q&A
09:00
12:30
Nurse Symposium (in Mandarin)
  • AKI跨領域團隊協作：結合院內警示系統與病人心理照護之整合模式
    Tzu-Chun Chen Speaker AKI跨領域團隊協作：結合院內警示系統與病人心理照護之整合模式急性腎損傷（Acute Kidney Injury, AKI）病人常因腎功能於短時間內惡化，面臨病情不確定、治療調整、可能接受腎臟替代療法及後續追蹤等壓力。AKI照護不僅需要即時醫療處置，更仰賴跨領域團隊透過資訊系統、臨床判斷與照護溝通，及早辨識高風險病人並啟動適切介入。 本次分享將以院內AKI警示系統推動經驗為核心，分享臨床如何運用燈號分級管理協助團隊掌握病人狀態。其中，黃色燈號代表系統出現AKI警示，提醒臨床團隊需提高警覺、追蹤腎功能變化並評估潛在風險；紅色燈號代表病人已有腎功能異常，但尚未由腎臟科收案，需進一步強化通報、評估與跨團隊銜接；綠色燈號則代表病人已由腎臟科收案，進入持續追蹤與專科共同照護流程。透過此分級機制，醫療團隊可更清楚掌握AKI病人之照護進程，降低風險辨識落差與照護延遲。 課程內容將進一步說明跨領域團隊在AKI照護中的合作角色，包括腎臟科醫師對腎功能異常與治療方向之評估，護理師於尿量、輸出入量、生命徵象、體液狀態與用藥安全之持續監測，藥師協助檢視腎毒性藥物與劑量調整，營養師提供符合腎功能狀態之營養建議，個案管理師協助追蹤、轉銜與衛教銜接，資訊團隊則透過警示系統支持臨床決策與照護流程優化。 除生理照護外，本課程亦將納入AKI病人的心理照護觀點。當病人得知腎功能異常、病況可能惡化或需接受透析評估時，常出現焦慮、害怕、失控感、對未來生活改變的擔憂，以及對家人造成負擔的壓力。護理人員可透過同理傾聽、清楚且一致的說明、評估病人與家屬的理解程度、提供可執行的照護建議，並在治療決策過程中融入共享決策與病人賦能，協助病人降低不確定感並提升治療參與感。 本課程期望透過院內AKI警示系統、紅黃綠燈號管理、跨領域團隊協作與心理照護經驗分享，強化醫療團隊對AKI病人之即時辨識、照護銜接、專科介入與人本支持能力，進一步提升AKI照護品質、病人安全與長期腎臟健康結果。
  • ​​重症 CRRT 照護的核心關鍵：適應症評估與警訊早期介入​
    Shu-Chen Wu Speaker ​​重症 CRRT 照護的核心關鍵：適應症評估與警訊早期介入​ 隨著重症醫學的進步，連續性腎替代療法（CRRT）已成為加護病房（ICU）救治多重器官衰竭與急性腎損傷（AKI）病患不可或缺的核心技術。本講座將引領與會者回顧 CRRT 的發展演進，從早期的基本血液淨化演進至當前精準的重症支持療法。內容將深入探討 CRRT 在加護病房中的關鍵臨床適應症，包括嚴重的體液過載、電解質與酸鹼失衡、以及敗血症引起的全身性發炎反應等處置決策。 此外，CRRT 治療過程中的機台警訊往往瞬息萬變，如何「早期發現、即時干預」是決定治療成敗與維持管路壽命的護理關鍵。本堂課將結合理論與近三十年的重症與透析臨床實務經驗，系統性解析常見的 CRRT 警訊（如跨膜壓高、動靜脈壓力異常等）之背後成因與臨床處置技巧。期能協助重症照護團隊建立預警思維，在警訊發生初期即能精準介入，優化重症病患的治療成效與照護品質。
  • 重症 CRRT從異常警報排除到跨團隊支持協作
    Li-Ming Wu Speaker 重症 CRRT從異常警報排除到跨團隊支持協作一、 進階臨床實務訓練（Simulation Training）上一堂課學到的「警報定義」與「併發症」，轉化為床邊執行的直覺反應。 （一）高壓/低壓警報的即時處置模擬：模擬動靜脈壓力異常（Access/Return Pressure）的床邊排除技巧。超濾率（Ultrafiltration）偏差與跨膜壓（TMP）過高的應變處置。 （二）無預警斷電或機件故障危機處理自動回血功能失效時，如何切換為「手動回血」流程，確保病人血液不流失 。 （三）極致管路與濾器防凝血策略：針對容易凝血的高風險病人，深入演練抗凝劑（如 Heparin 或局部檸檬酸抗凝法 Regional Citrate Anticoagulation, RCA）的精準劑量調控與床邊監測 。 二、 CRRT 跨團隊照護協作（Multidisciplinary Collaboration）： （一）醫護共同決策 ──「早期啟動」與「動態撤離」：建立 ICU 重症醫師與護理師的共同語言，依據病人的血流動力學變化的關鍵指標，動態調整治療參數 。 （二）護藥聯手 ── 藥物劑量動態精準調整（重症藥師協作）：延續上一堂提到的「低分子量與游離態藥物易被清除」之痛點 。 核心訓練： 如何與重症藥師配合，針對抗生素（如 Vancomycin、Meropenem）在 CRRT 運作期間進行動態血中濃度監測（TDM）與劑量補償，避免治療濃度不足 。 （三）護營協作 ── 高流量透析下的營養支持（營養師協作）：針對簡報提及「確保足夠營養支持」 進行具體實作。 重症營養師如何評估 CRRT 清除掉的氨基酸與微量元素，精準計算並給予適當的靜脈/腸道營養配方（TPN/EN） 。 三、 跨團隊溝通與危急資源管理（CRM）重症團隊的關鍵溝通（Structured Communication）：運用 ISBAR 溝通工具，在病人血壓崩潰 、嚴重酸中毒 或大量漏血 的危急時刻，護理師如何向醫師團隊精確回報，引導團隊快速決策。 交班盲點與連續性照護品質（Quality Indicator）：制定 ICU 白班、夜班，以及血液透析室護理師之間的優化交班檢核表（Checklist），包含管路壽命評估、累積出入量平衡（Fluid Balance）的交接 。
  • AKI 病人血液透析期間照護決策
    Chiung-Yu Shih Speaker AKI病人血液透析期間照護決策急性腎損傷(Acute kidney injury, AKI)是住院病人(約5%~10%)中常出現的疾病，尤其是重症病人(約60%)伴隨有多重共病症者，其發生原因甚多，且會明顯增加病人的發病率和死亡率，不應被視為單一疾病；其臨床處置需更瞭解體液和電解質的平衡，給予評估及決策適當的透析治療模式；然其模式決策的選擇，應依血流動力學的穩定性進行評估。不穩定者優先採用連續性腎臟替代治療（CRRT）或緩慢低效率每日血液透析過濾術(SLEDD-f)，以降低心血管負荷；穩定者則可選用間歇性血液透析（IHD），避免透析中低血壓，造成腎臟再次缺血損傷；同時需每日評估並滾動式調整透析醫囑與電解質參數，維持治療穩定安全。 綜論，建立標準化的AKI預防處置，抉擇適當的透析治療策略及臨床照護，確保病人安全，在清除素毒與血流動力學穩定下，阻斷AKI的病程，以促進腎功能的恢復。 課程重點大綱:1.AKI病人透析適應症判斷 2.透析模式選擇 3.透析期間常見併發症 4.護理決策與即時處置
  • 急性腎損傷病人血液透析的照護缺口：第一線護理師的臨床決策與實務分享
    Li-Hwa Tsai Speaker 急性腎損傷病人血液透析的照護缺口：第一線護理師的臨床決策與實務分享臨床實務上，發對於急性腎損傷（AKI）病人血液透析的照護缺乏系統化的指引，導致前、中、後期的照護決策流於破碎與被動執行醫囑。本次報告將從第一線臨床實務出發，分享如何建構「三階段全期護理照護決策地圖」。內容橫跨三核心階段：(1) 啟動期扮演安全守門員，結合生理數據給予個體化透析處方建議；(2)透析中利用早期預警指標，在低血壓發生前主動決策介入，嚴防二次腎損傷；(3)返家/出院期透過結構化照護，延續病人自我管理。期盼藉由本次現狀分享與交流，推動標準化照護共識，彰顯護理人員在動態決策中的關鍵價值，進而優化AKI病人的臨床預後。
  • AKI-to-CKD 智能照護流程建構與實務成效
    I-Chen Lee Speaker AKI-to-CKD 智能照護流程建構與實務成效急性腎損傷（Acute Kidney Injury, AKI）為住院病人常見且高風險之臨床問題，若未及早辨識與介入，可能進展為急性腎臟病（AKD）甚至慢性腎臟病（CKD），增加透析、再住院及死亡風險。本院透過資訊系統整合，建立 AKI E-alert System，利用住院、急診及門診血清肌酸酐（Serum Creatinine）變化，自動比對基準值，依據 KDIGO 標準進行 AKI 分期與警示，提升臨床團隊對 AKI 病人的即時辨識能力。進一步結合台灣健保 AKD 與 CKD 照護條件，建置 CKD MAP，並導入 One Team 住院個案管理系統，整合腎臟科醫師、個管師、護理師、藥師及營養師跨團隊照護流程。系統可自動篩選符合收案條件之病人，協助個案管理介入、腎毒性藥物檢視、營養與衛教評估，以及出院後 AKD/CKD 門診追蹤轉介，建立完整 AKI-to-CKD 照護鏈結。本次分享將介紹本院 AKI 智能警示系統架構、AKD照護流程設計、跨團隊照護模式及資訊整合策略，並呈現導入後之收案率、腎臟科會診率、個案追蹤率及照護效益成果。期望透過數位轉型與精準照護模式，提升 AKI 病人早期介入與長期腎臟保護成效，作為未來 AKI-to-CKD 整合照護之實務參考。
  • 急性腎損傷個案管理策略
    Chiao-Chuan Huang Speaker 急性腎損傷個案管理策略本院推行以病人為中心之急性腎損傷個案管理策略，落實跨團隊衛教機制，強化病人對疾病進程的認知，以提升定期接受腎臟專科追蹤之遵從性。護理師教導AKD惡化因子及日常照護，並建立用藥安全觀念，如：避免自行服用 NSAIDs 等腎毒性藥物。導入智能化資訊系統主動篩選符合條件病人，即時提示醫療團隊進行AKD照護，本照護模式透過「病人自主、醫護精準、資訊智能」期能達到早期發現、即時介入，以降低 AKD惡化為慢性腎臟病（CKD）之風險。
  • 衛教師經驗分享：衛教師的角色與實務觀點
    Tsung-Lin Wu Speaker
  • Q&A
10:15
10:45
Coffee Break
10:45
12:30
Plenary 2: AKI Pathophysiology
Shih-Chi Ku Moderator
12:40
13:45
Lunch Symposium 1 (Vantive)
Lunch Symposium 2 (CytoSorb)
Lunch Symposium 3 (FMC)
Thomas Tao-Min Huang Moderator Overview of Acute kidney injury and Continuous Renal Replacement Therapy in Critical Care本演講概述重症病人急性腎損傷與 CRRT 之臨床決策、適應症、處方原則與治療監測，強化從決策到執行的實務能力。
14:00
15:30
Workshop 1 - Session A
Precision Solute Control and Dynamic Dosing with CRRT
Workshop 1 - Session B
Managing Patients With Combined Kidney and Liver Failure
  • Managing Patients With Combined Kidney and Liver Failure
    Ashita Tolwani Speaker The ABC of the CRRT prescriptionPrescribing continuous renal replacement therapy requires an understanding of how modality, blood flow, treatment dose, replacement-fluid delivery, and circuit factors influence therapy delivery. This presentation will provide a practical framework for developing and evaluating a CRRT prescription, including the principles of diffusive and convective clearance, prescribed versus delivered dose, and the impact of replacement-fluid location and treatment interruptions. Clinical examples will highlight common prescribing challenges and demonstrate how CRRT settings can be adjusted to meet changing patient needs while maintaining effective and safe therapy.AnticoagulationEffective anticoagulation is essential to maintain circuit patency, minimize blood loss, and ensure delivery of the prescribed CRRT dose. This presentation will review the principles guiding anticoagulant selection during CRRT, including the relative roles of regional citrate anticoagulation, unfractionated heparin, and alternative agents. Particular emphasis will be placed on balancing circuit longevity with patient safety, recognizing patients at increased risk for bleeding or citrate intolerance, and monitoring for metabolic and anticoagulation-related complications. Dysnatremia and acid-base disordersContinuous renal replacement therapy can be adapted to safely manage severe sodium and acid–base disturbances. This presentation will review a practical approach to modifying the CRRT prescription based on the patient’s serum sodium, acid–base status, and desired rate of correction. Emphasis will be placed on anticipating how CRRT solutions and treatment settings influence biochemical changes and on avoiding overly rapid correction or treatment-related complications. Clinical examples will illustrate key principles for individualized therapy.Severe hypernatremia and hyperkalemia in AKI requiring KRTManaging Patients With Combined Kidney and Liver Failure
    Mitra Nadim Speaker Hepatorenal Syndrome: Recognition and Management or Disordered Physiology or Iatrogenic FailureManaging Patients With Combined Kidney and Liver FailureHow do I Manage Patients with Combined Kidney and Liver Failure
    Ju-Yeh Yang Moderator
Workshop 1 - Session C
Managing Patients with Sepsis: Modifying the Course with ECOS
Workshop 1 - Session D
How Do I Care for the Patient with ARDS and AKI
  • How Do I Care for the Patient with ARDS and AKI
    Kathleen Liu Speaker How do I Manage Patients with Combined Kidney and Liver FailureKidney-Ventilator Interactions and Kidney Protective Ventilation /or Lung and Kidney CrosstalkHow do I care for the Patient with ARDS and AKIDe-escalating and Transitioning RRT: Best Practices
    Keith Wille Speaker Connectology with Hybrid Systems: ECMO, Apheresis, ECCO2RAKI in the Mechanical Circulatory SupportHow do I care for the Patient with ARDS and AKI
    Chien-Liang Chen Moderator
    Chien-Yu Lin Moderator
Regional Symposium (AI/Big data)
Chia-Chao Wu Moderator
Chin-Chung Tseng Moderator
  • Chair's Opening: Framing AI + Big Data Along the AKI/CRRT Care Pathway
    Chia-Chao Wu Speaker
    Chin-Chung Tseng Speaker
  • Korean Big-Data Experience in AKI and CRRT Outcomes
    Sejoong Kim Speaker Korean Big-Data Experience in AKI and CRRT OutcomesSouth Korea has established a robust nationwide health data infrastructure, enabling large-scale analyses of acute kidney injury (AKI) and continuous renal replacement therapy (CRRT). Leveraging the Health Insurance Review and Assessment Service (HIRA) and National Health Insurance Service (NHIS) databases, Korean researchers have characterized AKI incidence, risk factors, and short- and long-term outcomes across diverse clinical settings. Studies utilizing CRRT data have identified predictors of mortality, renal recovery, and progression to chronic kidney disease. These big-data approaches provide critical real-world evidence, informing clinical practice and guiding future interventional strategies in critically ill patients with AKI.Precision Volume Management in CRRT: Insights from Bioimpedance and BiomarkersOptimal fluid balance is critical in critically ill patients undergoing continuous renal replacement therapy (CRRT), yet accurate volume assessment remains challenging. Bioimpedance analysis (BIA) offers a non-invasive, objective method to quantify fluid overload and guide individualized ultrafiltration targets. Complementing BIA, emerging biomarkers provide dynamic, real-time insights into volume status and end-organ perfusion. Integrating these tools into a precision medicine framework may optimize fluid removal strategies, reduce complications, and improve survival outcomes in CRRT-dependent patients. Prospective validation of this combined approach is warranted.
  • Deep Learning ECG as a Non-Invasive Window into Kidney Function and Electrolytes
    Chin Lin Speaker Deep Learning Electrocardiography as a Non-Invasive Window into Kidney Function and Electrolyte DisturbancesRecent advances in deep learning have transformed the standard 12-lead electrocardiogram (ECG) from a tool for rhythm interpretation into a scalable physiologic sensor capable of detecting systemic disease. In this lecture, we will review the development and clinical translation of AI-enabled ECG models for dyskalemia detection and renal-function estimation. Using large real-world cohorts, convolutional and attention-based neural networks have demonstrated high accuracy for identifying moderate-to-severe hyperkalemia and hypokalemia directly from ECG waveforms, frequently preceding laboratory confirmation and outperforming clinician interpretation. Beyond electrolyte detection, AI-ECG signatures were also associated with adverse outcomes, cardiovascular risk, and future chronic kidney disease progression, even among patients with apparently normal laboratory findings. We will further discuss pragmatic deployment studies showing how real-time AI-ECG alerts integrated into emergency department workflows can accelerate treatment decisions for life-threatening hyperkalemia. Finally, the talk will address how signal-based AI can complement EHR-based prediction models in critical-care nephrology, including issues of interpretability, calibration drift, implementation, and multimodal foundation-model integration.
  • AI in Critical Care Nephrology — State of the Art and the Path from Algorithm to Bedside
    Kianoush Kashani Speaker Practical Steps to Train (and Become) an AI-Era PhysicianAI in Critical Care Nephrology — State of the Art and the Path from Algorithm to BedsideLate breaking clinical trials or Critical Care Nephrology: Literature Review AI in the ICU or Chat GPT Applications in Critical Care Nephrology
  • Precision Sepsis-AKI — Biomarkers, AI and Phenotyping in the Asia-Pacific
    Nattachai Srisawat Speaker Precision Sepsis-AKI — Biomarkers, AI and Phenotyping in the Asia-PacificTiming of DialysisAcute PD vs Acute HD: Which Is the Right Choice?
  • Panel Discussion
    Chin Lin Speaker Deep Learning Electrocardiography as a Non-Invasive Window into Kidney Function and Electrolyte DisturbancesRecent advances in deep learning have transformed the standard 12-lead electrocardiogram (ECG) from a tool for rhythm interpretation into a scalable physiologic sensor capable of detecting systemic disease. In this lecture, we will review the development and clinical translation of AI-enabled ECG models for dyskalemia detection and renal-function estimation. Using large real-world cohorts, convolutional and attention-based neural networks have demonstrated high accuracy for identifying moderate-to-severe hyperkalemia and hypokalemia directly from ECG waveforms, frequently preceding laboratory confirmation and outperforming clinician interpretation. Beyond electrolyte detection, AI-ECG signatures were also associated with adverse outcomes, cardiovascular risk, and future chronic kidney disease progression, even among patients with apparently normal laboratory findings. We will further discuss pragmatic deployment studies showing how real-time AI-ECG alerts integrated into emergency department workflows can accelerate treatment decisions for life-threatening hyperkalemia. Finally, the talk will address how signal-based AI can complement EHR-based prediction models in critical-care nephrology, including issues of interpretability, calibration drift, implementation, and multimodal foundation-model integration.
    Kianoush Kashani Speaker Practical Steps to Train (and Become) an AI-Era PhysicianAI in Critical Care Nephrology — State of the Art and the Path from Algorithm to BedsideLate breaking clinical trials or Critical Care Nephrology: Literature Review AI in the ICU or Chat GPT Applications in Critical Care Nephrology
    Nattachai Srisawat Speaker Precision Sepsis-AKI — Biomarkers, AI and Phenotyping in the Asia-PacificTiming of DialysisAcute PD vs Acute HD: Which Is the Right Choice?
    Sejoong Kim Speaker Korean Big-Data Experience in AKI and CRRT OutcomesSouth Korea has established a robust nationwide health data infrastructure, enabling large-scale analyses of acute kidney injury (AKI) and continuous renal replacement therapy (CRRT). Leveraging the Health Insurance Review and Assessment Service (HIRA) and National Health Insurance Service (NHIS) databases, Korean researchers have characterized AKI incidence, risk factors, and short- and long-term outcomes across diverse clinical settings. Studies utilizing CRRT data have identified predictors of mortality, renal recovery, and progression to chronic kidney disease. These big-data approaches provide critical real-world evidence, informing clinical practice and guiding future interventional strategies in critically ill patients with AKI.Precision Volume Management in CRRT: Insights from Bioimpedance and BiomarkersOptimal fluid balance is critical in critically ill patients undergoing continuous renal replacement therapy (CRRT), yet accurate volume assessment remains challenging. Bioimpedance analysis (BIA) offers a non-invasive, objective method to quantify fluid overload and guide individualized ultrafiltration targets. Complementing BIA, emerging biomarkers provide dynamic, real-time insights into volume status and end-organ perfusion. Integrating these tools into a precision medicine framework may optimize fluid removal strategies, reduce complications, and improve survival outcomes in CRRT-dependent patients. Prospective validation of this combined approach is warranted.
  • Chair's Synthesis and Take-Home Points
    Chia-Chao Wu Speaker
    Chin-Chung Tseng Speaker
Workhsop by Vantive (TBD)
  • Opening
    Wei-Lun Liu Speaker
  • Overview of Acute Kidney Injury and Continuous Renal Replacement Therapy in Critical Care
    Thomas Tao-Min Huang Speaker Overview of Acute kidney injury and Continuous Renal Replacement Therapy in Critical Care本演講概述重症病人急性腎損傷與 CRRT 之臨床決策、適應症、處方原則與治療監測，強化從決策到執行的實務能力。
  • Break
  • Station 1- PrisMax and ECCO2R Demo
    Chih-Heng Chang Speaker PrisMax and ECCO2R demoWe provides a hands-on demonstration of the Baxter Prismaflex/PrisMax system integrated with extracorporeal CO₂ removal (ECCO₂R) technology. Participants will explore the operational principles of ECCO₂R, including membrane lung mechanics, CO₂ clearance efficiency, and circuit management. The session will address clinical indications Practical setup, troubleshooting, and patient monitoring strategies will be demonstrated on the PrisMax platform. • PrisMax 系統實機示範 • ECCO2R（體外二氧化碳移除）應用介紹 • 幫助學員熟悉設備操作與臨床使用情境
    Wei-Lun Liu Moderator
  • Station 2- APAC Oxiris Expert Consensus Briefing
    I-Hsien Lee Speaker APAC Oxiris Expert Consensus briefing• APAC 專家共識重點解析 • 著重於敗血症與發炎反應治療應用 • 協助理解何時使用、如何選擇 第二站聚焦於Oxiris相關之國際專家共識解讀，說明其在敗血症及重症發炎反應中的使用策略，協助醫療人員理解治療時機與選擇依據。
    Wei-Lun Liu Speaker
  • Station 3 – Practical CRRT Prescription and Regional Citrate Anticoagulation
    Bo-Tang Wang Speaker 檸檬酸抗凝治療, CRRT處方設定原則本課程將介紹檸檬酸局部抗凝在連續性腎臟替代治療（CRRT）中的原理、應用與臨床操作要點。內容涵蓋檸檬酸抗凝原理、鈣離子監測與補充策略，以及常見併發症如低鈣血症、代謝性酸鹼中毒的處置。課程亦將透過案例討論協助學員理解參數設定與調整原則，提升 CRRT 治療安全性與療效。
    Wei-Lun Liu Moderator
  • Closing
    Wei-Lun Liu Speaker
15:30
16:00
Coffee Break
16:00
17:40
Plenary 3: Challenges in ICU Management/ Update From Ongoing Trial and Late Breaking Trial
Shih-Yuan Hung Moderator
Debate Semifinal Round
Cheng-Chia Lee Moderator
ECMO, AKI, and RRT: Consensus, Controversies, and Bedside Decision-Making.
Regional Symposium (AKD/EBM)
AKD in Asia-Pacific: Post-AKI Recovery, Critical Illness, and Regional Phenotypes
Tai-Shuan Lai Moderator
WEIHUNG Lin Moderator
17:30
18:00
Group Photo
18:00
19:00
Poster Walk & Mini‑Oral Presentation 2
Ming-Jen Chan Moderator
Ting-Yu Chiou Moderator
19:00
21:00
Gala Dinner
4F Phoenix Hall, TICC